Literature DB >> 23382630

Effect of alcohol consumption on liver stiffness measured by transient elastography.

Edouard Bardou-Jacquet1, Ludivine Legros, Draman Soro, Marianne Latournerie, Anne Guillygomarc'h, Caroline Le Lan, Pierre Brissot, Dominique Guyader, Romain Moirand.   

Abstract

AIM: To determine the evolution of transient elastography (TE) in patients with alcoholic liver disease according to alcohol cessation or continuation.
METHODS: We retrospectively selected in our local database all patients who had two TE between June 2005 and November 2010 with chronic alcohol excessive consumption and excluded those with associated cause of liver disease. TE was performed at least one week apart by senior operator. TE examinations with less than ten successful measures or with an interquartile range above 30% were excluded. We retrospectively reviewed file of all patients to include only patient followed up by trained addictologist and for which definite information on alcohol consumption was available. Concomitant biological parameters [aspartate amino transferase (AST), alanine amino transferase and gamma-glutamyl transpeptidase (GGT)] within 4 wk of initial and final TE were recorded. Putative fibrosis score according to initial and final TE were determined with available cut-off for alcoholic liver disease and hepatitis C. Initial and final putative fibrosis score were compared according to alcohol consumption during follow-up.
RESULTS: During the study period 572 patients had TE examination for alcoholic liver disease and 79 of them had at least two examinations. Thirty-seven patients met our criteria with a median follow-up of 32.5 wk. At the end of the study, 13 (35%) were abstinent, and 24 (65%) relapsers. Eight patients had liver biopsy during follow-up. TE decreased significantly during follow-up in 85% of abstinent patients [median (range): -4.9 (-6.1,-1.9)], leading to a modification of the putative fibrosis stage in 28%-71% of patient according to different cut-off value. In relapsers TE increased in 45% and decreased in 54% of patient. There was no statistical difference between initial and final TE in relapsers. In the overall population, using 22.6 kPa as cut-off for cirrhosis, 4 patients had cirrhosis at initial TE and 3 patients had cirrhosis at final TE. Using 19.5 kPa as cut-off for cirrhosis, 7 patients had cirrhosis at initial TE and 5 patients had cirrhosis at final TE. Using 12.5 kPa as cut-off for cirrhosis, 16 patients had cirrhosis at initial TE and 15 patients had cirrhosis at final TE. Evolution of biological data was in accordance with the relapse or abstinent status: abstinence ratio (duration of abstinence/duration follow-up) was correlated with AST ratio (r = -0.465, P = 0.007) and GGT ratio (r = -0.662, P < 0.0001). GGT was correlated with initial (r = 0.488, P = 0.002) and final TE (r = 0.49, P < 0.005). Final TE was correlated with AST (r = 0.362, P < 0.05). Correlation between TE ratio and AST ratio (r = 0.44, P = 0.01) revealed that TE varied proportionally to AST for all patients irrespective of their alcohol status. The same relationship was observed between TE ratio and GGT ratio (r = 0.65, P < 0.0001). Evolution of TE was significantly correlated with the ratio of time of abstinence to observation time (r = -0.387, P = 0.016) and the evolution of liver enzymes.
CONCLUSION: TE significantly decreased with abstinence. Results of TE in alcoholic liver disease cannot be interpreted without taking into account alcohol consumption and liver enzymes.

Entities:  

Keywords:  Alcohol; Cirrhosis; Fibrosis; Liver biopsy; Liver stiffness; Transient elastography

Mesh:

Substances:

Year:  2013        PMID: 23382630      PMCID: PMC3558575          DOI: 10.3748/wjg.v19.i4.516

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Pain experienced during percutaneous liver biopsy.

Authors:  L Castéra; I Nègre; K Samii; C Buffet
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

2.  Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy.

Authors:  Marcello Persico; Bruno Palmentieri; Raffaela Vecchione; Roberto Torella; Sio Ilario de
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

3.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2012-04       Impact factor: 25.083

4.  An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group.

Authors:  P Bedossa; T Poynard
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

5.  Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

Authors:  Christophe Corpechot; Ahmed El Naggar; Armelle Poujol-Robert; Marianne Ziol; Dominique Wendum; Olivier Chazouillères; Victor de Lédinghen; Daniel Dhumeaux; Patrick Marcellin; Michel Beaugrand; Raoul Poupon
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

6.  Palpable epigastric liver as a physical sign of cirrhosis: a prospective study.

Authors:  P A McCormick; N Nolan
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-11       Impact factor: 2.566

Review 7.  Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress.

Authors:  Helmut K Seitz; Felix Stickel
Journal:  Biol Chem       Date:  2006-04       Impact factor: 3.915

8.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

9.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

Authors:  Marianne Ziol; Adriana Handra-Luca; Adrien Kettaneh; Christos Christidis; Frédéric Mal; Farhad Kazemi; Victor de Lédinghen; Patrick Marcellin; Daniel Dhumeaux; Jean-Claude Trinchet; Michel Beaugrand
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

10.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.

Authors:  F Piccinino; E Sagnelli; G Pasquale; G Giusti
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

View more
  17 in total

1.  Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.

Authors:  Daniel L Motola; Peter Caravan; Raymond T Chung; Bryan C Fuchs
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 2.  Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(®)).

Authors:  Monica Lupsor-Platon; Radu Badea
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Non invasive tools for the diagnosis of liver cirrhosis.

Authors:  Maurizio Soresi; Lydia Giannitrapani; Melchiorre Cervello; Anna Licata; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 4.  Therapy for alcoholic liver disease.

Authors:  Maryconi M Jaurigue; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 5.  Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.

Authors:  Paul Kennedy; Mathilde Wagner; Laurent Castéra; Cheng William Hong; Curtis L Johnson; Claude B Sirlin; Bachir Taouli
Journal:  Radiology       Date:  2018-03       Impact factor: 11.105

6.  Acoustic radiation force impulse imaging for assessing liver fibrosis in alcoholic liver disease.

Authors:  Anita Kiani; Vanessa Brun; Fabrice Lainé; Bruno Turlin; Jeff Morcet; Sophie Michalak; Antonia Le Gruyer; Ludivine Legros; Edouard Bardou-Jacquet; Yves Gandon; Romain Moirand
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

Review 7.  Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.

Authors:  Chavdar S Pavlov; Giovanni Casazza; Dimitrinka Nikolova; Emmanuel Tsochatzis; Andrew K Burroughs; Vladimir T Ivashkin; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-01-22

Review 8.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

9.  Early Detection of Alcoholic Liver Disease: Are We a Step Closer?

Authors:  Suthat Liangpunsakul; David W Crabb
Journal:  Gastroenterology       Date:  2015-11-22       Impact factor: 22.682

10.  Looking beyond appearances: when liver biopsy is the key for hepatic tuberculosis diagnosis.

Authors:  Marta Freitas; Joana Magalhães; Carla Marinho; José Cotter
Journal:  BMJ Case Rep       Date:  2020-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.